Literature DB >> 18774645

Analgesic effect in rodents of native and recombinant Ph alpha 1beta toxin, a high-voltage-activated calcium channel blocker isolated from armed spider venom.

Alessandra H Souza1, Juliano Ferreira, Marta do Nascimento Cordeiro, Luciene Bruno Vieira, Celio J De Castro, Gabriela Trevisan, Helton Reis, Ivana Assis Souza, Michael Richardson, Marco A M Prado, Vânia F Prado, Marcus Vinicius Gomez.   

Abstract

Calcium influx through neuronal voltage-sensitive calcium channels (VSCC S) mediates nociceptive information in the spinal dorsal horn. In fact, spinally administered VSCC S blockers, such as omega-conotoxin MVIIA, have analgesic effect apart of their low therapeutic index and many side effects. Here we study the analgesic potential of Ph alpha 1beta, a calcium channel blocker, in rodent models of acute and persistent pain. Spinally administered Ph alpha 1beta showed higher efficacy and long-lasting analgesia in a thermal model of pain, when compared with omega-conotoxin MVIIA. Moreover, Ph alpha 1beta was more effective and potent than omega-conotoxin MVIIA not only to prevent, but especially to reverse, previously installed persistent chemical and neuropathic pain. Furthermore, the analgesic action of both toxins are related with the inhibition of Ca2+-evoked release of pro-nociceptive neurotransmitter, glutamate, from rat spinal cord synaptosomes and decrease of glutamate overflow in cerebrospinal fluid. When side effects were assessed, we found that Ph alpha 1beta had a therapeutic index wider than omega- conotoxin MVIIA. Finally, recombinant Ph alpha 1beta expressed in Escherichia coli showed marked analgesic activity similar to the native toxin. Taken together, the present study demonstrates that native and recombinant Ph alpha 1beta have analgesic effects in rodent models of pain, suggesting that this toxin may have potential to be used as a drug in the control of persistent pathological pain.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18774645     DOI: 10.1016/j.pain.2008.07.014

Source DB:  PubMed          Journal:  Pain        ISSN: 0304-3959            Impact factor:   6.961


  26 in total

1.  Spinal actions of ω-conotoxins, CVID, MVIIA and related peptides in a rat neuropathic pain model.

Authors:  A Jayamanne; H J Jeong; C I Schroeder; R J Lewis; M J Christie; C W Vaughan
Journal:  Br J Pharmacol       Date:  2013-09       Impact factor: 8.739

2.  Inhibition of transmitter release and attenuation of anti-retroviral-associated and tibial nerve injury-related painful peripheral neuropathy by novel synthetic Ca2+ channel peptides.

Authors:  Sarah M Wilson; Brian S Schmutzler; Joel M Brittain; Erik T Dustrude; Matthew S Ripsch; Jessica J Pellman; Tae-Sung Yeum; Joyce H Hurley; Cynthia M Hingtgen; Fletcher A White; Rajesh Khanna
Journal:  J Biol Chem       Date:  2012-08-13       Impact factor: 5.157

Review 3.  Anticancer, antimicrobial, and analgesic activities of spider venoms.

Authors:  Hassan M Akef
Journal:  Toxicol Res (Camb)       Date:  2018-03-08       Impact factor: 3.524

4.  Antinociceptive effect of a novel armed spider peptide Tx3-5 in pathological pain models in mice.

Authors:  Sara M Oliveira; Cássia R Silva; Gabriela Trevisan; Jardel G Villarinho; Marta N Cordeiro; Michael Richardson; Márcia H Borges; Célio J Castro; Marcus V Gomez; Juliano Ferreira
Journal:  Pflugers Arch       Date:  2016-02-22       Impact factor: 3.657

5.  Structural Characterization and Disulfide Assignment of Spider Peptide Phα1β by Mass Spectrometry.

Authors:  Kelly L Wormwood; Armand Gatien Ngounou Wetie; Marcus Vinicius Gomez; Yue Ju; Paul Kowalski; Marius Mihasan; Costel C Darie
Journal:  J Am Soc Mass Spectrom       Date:  2018-04-16       Impact factor: 3.109

6.  The peptide Phα1β, from spider venom, acts as a TRPA1 channel antagonist with antinociceptive effects in mice.

Authors:  Raquel Tonello; Camilla Fusi; Serena Materazzi; Ilaria M Marone; Francesco De Logu; Silvia Benemei; Muryel C Gonçalves; Elisabetta Coppi; Celio J Castro-Junior; Marcus Vinicius Gomez; Pierangelo Geppetti; Juliano Ferreira; Romina Nassini
Journal:  Br J Pharmacol       Date:  2016-11-28       Impact factor: 8.739

7.  The inhibitory effect of Phα1β toxin on diabetic neuropathic pain involves the CXCR4 chemokine receptor.

Authors:  Claudio Antonio da Silva Junior; Célio José de Castro Junior; Elizete Maria Rita Pereira; Nancy Scardua Binda; Juliana Figueira da Silva; Marta do Nascimento Cordeiro; Danuza Montijo Diniz; Flavia Santa Cecilia; Juliano Ferreira; Marcus Vinicius Gomez
Journal:  Pharmacol Rep       Date:  2020-01-08       Impact factor: 3.024

8.  PnPP-19, a spider toxin peptide, induces peripheral antinociception through opioid and cannabinoid receptors and inhibition of neutral endopeptidase.

Authors:  A C N Freitas; D F Pacheco; M F M Machado; A K Carmona; I D G Duarte; M E de Lima
Journal:  Br J Pharmacol       Date:  2016-03-10       Impact factor: 8.739

9.  An evaluation of the antinociceptive effects of Phα1β, a neurotoxin from the spider Phoneutria nigriventer, and ω-conotoxin MVIIA, a cone snail Conus magus toxin, in rat model of inflammatory and neuropathic pain.

Authors:  Alessandra Hubner de Souza; Célio J Castro; Flavia Karine Rigo; Sara Marchesan de Oliveira; Renato Santiago Gomez; Danuza Montijo Diniz; Marcia Helena Borges; Marta Nascimento Cordeiro; Marco Aurélio Romano Silva; Juliano Ferreira; Marcus Vinicius Gomez
Journal:  Cell Mol Neurobiol       Date:  2012-08-07       Impact factor: 5.046

10.  Antinociceptive and genotoxic assessments of the antagonist TRPV1 receptor SB-366791 on morphine-induced tolerance in mice.

Authors:  Thiago Kastell Mazeto; Jaqueline Nascimento Picada; Áurea Pandolfo Correa; Isadora Nunes Rebelo; Magali Terra Ribeiro; Marcus Vinícius Gomez; Alessandra Hubner de Souza
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2019-10-26       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.